BRPI0614521B8 - indicador de oxigênio para uso em produtos médicos - Google Patents

indicador de oxigênio para uso em produtos médicos

Info

Publication number
BRPI0614521B8
BRPI0614521B8 BRPI0614521A BRPI0614521A BRPI0614521B8 BR PI0614521 B8 BRPI0614521 B8 BR PI0614521B8 BR PI0614521 A BRPI0614521 A BR PI0614521A BR PI0614521 A BRPI0614521 A BR PI0614521A BR PI0614521 B8 BRPI0614521 B8 BR PI0614521B8
Authority
BR
Brazil
Prior art keywords
container
chamber
longitudinal length
additional chamber
chambers
Prior art date
Application number
BRPI0614521A
Other languages
English (en)
Inventor
Melin Christian
Bonnot Denis
Desbrosses Freddy
Trouilly Jean-Luc
Original Assignee
Baxter Healthcare Sa
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37434338&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0614521(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Healthcare Sa, Baxter Int filed Critical Baxter Healthcare Sa
Publication of BRPI0614521A2 publication Critical patent/BRPI0614521A2/pt
Publication of BRPI0614521B1 publication Critical patent/BRPI0614521B1/pt
Publication of BRPI0614521B8 publication Critical patent/BRPI0614521B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B27/00—Layered products comprising a layer of synthetic resin
    • B32B27/06—Layered products comprising a layer of synthetic resin as the main or only constituent of a layer, which is next to another layer of the same or of a different material
    • B32B27/08—Layered products comprising a layer of synthetic resin as the main or only constituent of a layer, which is next to another layer of the same or of a different material of synthetic resin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
    • G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
    • G01N31/223—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators for investigating presence of specific gases or aerosols
    • G01N31/225—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators for investigating presence of specific gases or aerosols for oxygen, e.g. including dissolved oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1462—Containers with provisions for hanging, e.g. integral adaptations of the container
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202—Separating means
    • A61J1/2024—Separating means having peelable seals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
    • G01N21/783—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour for analysing gases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pediatric Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)

Abstract

indicador de oxigênio para uso em produtos médicos. a presente invenção refere-se a um indicador de oxigênio que é fornecido para revelar a presença de oxigênio em um recipiente que aloja uma formulação médica. o indicador pode ser formulado com componentes considerados seguros para uso com produtos médicos. um indicador de oxigênio preferido deve ser resistente à termo-esterilização e ao armazenamento prolongado e prover uma mudança de cor distinta e acentuada para indicar que o oxigênio está presente. de preferência, o indicador deve ser fabricado na forma oxidada e reduzido mediante esterilização por vapor. além disso, tanto a cor da forma reduzida quanto a cor da forma oxidada não devem desbotar nem alterar de maneira significativa durante o armazenamento. ademais, uma vez que tenha corrido uma alteração de cor indicando a presença do oxigênio, a cor oxidada permanece, de preferência, substancialmente inalterada, de modo visual, para o observador, mesmo após um armazenamento prolongado, o indicador de oxigênio pode ser alojado em uma bolsa ou embalagem polimérica com uma parte transparente para que a cor do indicador seja observada.
BRPI0614521A 2005-08-02 2006-08-02 indicador de oxigênio para uso em produtos médicos BRPI0614521B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70455505P 2005-08-02 2005-08-02
US60/704,555 2005-08-02
PCT/US2006/030051 WO2007016611A2 (en) 2005-08-02 2006-08-02 Oxygen indicator for use in medical products

Publications (3)

Publication Number Publication Date
BRPI0614521A2 BRPI0614521A2 (pt) 2011-03-29
BRPI0614521B1 BRPI0614521B1 (pt) 2021-02-23
BRPI0614521B8 true BRPI0614521B8 (pt) 2021-06-22

Family

ID=37434338

Family Applications (3)

Application Number Title Priority Date Filing Date
BRPI0614097A BRPI0614097B8 (pt) 2005-08-02 2006-08-02 recipiente flexível para o armazenamento de produtos médicos
BRPI0614606-6A BRPI0614606A2 (pt) 2005-08-02 2006-08-02 produtos médicos e formulações parenterais
BRPI0614521A BRPI0614521B8 (pt) 2005-08-02 2006-08-02 indicador de oxigênio para uso em produtos médicos

Family Applications Before (2)

Application Number Title Priority Date Filing Date
BRPI0614097A BRPI0614097B8 (pt) 2005-08-02 2006-08-02 recipiente flexível para o armazenamento de produtos médicos
BRPI0614606-6A BRPI0614606A2 (pt) 2005-08-02 2006-08-02 produtos médicos e formulações parenterais

Country Status (19)

Country Link
US (3) US20070092579A1 (pt)
EP (3) EP1909736B1 (pt)
JP (3) JP2009502436A (pt)
KR (3) KR20080043804A (pt)
CN (3) CN101277670B (pt)
AT (1) ATE493105T1 (pt)
AU (3) AU2006295338B2 (pt)
BR (3) BRPI0614097B8 (pt)
CA (3) CA2616928C (pt)
DE (1) DE602006019259D1 (pt)
DK (2) DK1909736T3 (pt)
ES (2) ES2525930T3 (pt)
HK (2) HK1121032A1 (pt)
IL (3) IL189196A (pt)
MX (3) MX2008001620A (pt)
NZ (2) NZ565765A (pt)
PT (2) PT1909739E (pt)
RU (3) RU2008108007A (pt)
WO (3) WO2007016611A2 (pt)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1621178A1 (en) * 2004-07-29 2006-02-01 Fresenius Kabi Deutschland GmbH Flexible multi-chamber container for the preparation of medical mixed solutions
EP1621177A1 (en) * 2004-07-29 2006-02-01 Fresenius Kabi Deutschland GmbH Medical container with improved peelable seal
US8603805B2 (en) 2005-04-22 2013-12-10 Hyclone Laboratories, Inc. Gas spargers and related container systems
JP4765653B2 (ja) * 2005-12-16 2011-09-07 凸版印刷株式会社 酸素インジケーター用インキ組成物およびそれを使用した酸素インジケーター並びに酸素インジケーターを含有する包装材料
US7618406B2 (en) * 2007-01-22 2009-11-17 Baxter International, Inc. Break seal before access dual chamber bag
WO2008109535A2 (en) * 2007-03-02 2008-09-12 Marvell International Ltd. Ink supply for a hand-held ink jet printer
DE102007028733A1 (de) 2007-06-21 2008-12-24 Fresenius Kabi Deutschland Gmbh Behältnis zur Verwendung in der enteralen Ernährung
US7658952B2 (en) * 2007-10-11 2010-02-09 Baxter International Inc. Dialysis solutions containing pyrophosphates
EP2244760B8 (en) * 2008-01-28 2022-07-20 Implantica Patent Ltd. An implantable drainage device
FI20085609A0 (fi) * 2008-06-18 2008-06-18 Valtion Teknillinen Happi-indikaattori
GB2494234B (en) * 2008-07-07 2013-08-07 Pentec Health Inc Nutritive compositions and methods of using same
US8808595B2 (en) * 2009-04-07 2014-08-19 Cryovac, Inc. Multilayer film for medical solution pouches having reduced proficiency for forming bubbles
EP2264448B1 (de) 2009-06-19 2016-11-09 B. Braun Melsungen AG Verwendung einer Zusammensetzung als Sauerstoffindikator für parenterale und enterale Applikationsformen
WO2011047178A1 (en) * 2009-10-14 2011-04-21 Gi Innovation, Pllc Colon cleansing of residual stool and secretions during colonoscopy
NZ601027A (en) * 2010-01-04 2014-08-29 Pentec Health Inc Nutritive compositions and methods of using same
EP2386286A1 (en) 2010-05-10 2011-11-16 B. Braun Melsungen AG Handling
EP2386284A1 (en) 2010-05-10 2011-11-16 B. Braun Melsungen AG Shape
EP2386283A1 (en) * 2010-05-10 2011-11-16 B. Braun Melsungen AG Filling
US20130126370A1 (en) 2010-06-17 2013-05-23 David DiLiberto Multi-compartment container with frangible seal and external means for applying opening force between compartments
EP2489408A1 (de) * 2011-01-13 2012-08-22 Michael Tchirikov Aminosäurezusammensetzung und deren Verwendung zur Behandlung von fetaler Wachstumsrestriktion (IUGR) und zur parenteralen Ernährung von extrem Frühgeborenen
US20120199205A1 (en) * 2011-02-03 2012-08-09 Fresenius Medical Care Deutschland Gmbh System for preparing a medical fluid and method for preparing a medical fluid
EP2484333B1 (en) * 2011-02-03 2017-11-15 Fresenius Medical Care Deutschland GmbH System for preparing a medical fluid
WO2012104405A1 (en) * 2011-02-03 2012-08-09 Fresenius Medical Care Deutschland Gmbh System for preparing a medical fluid and method for preparing a medical fluid
EP2537541A1 (en) * 2011-06-23 2012-12-26 Metpro AB Container and connector for providing a medical solution
US8979817B2 (en) * 2011-07-14 2015-03-17 Fenwal, Inc. Multi-chamber container with seal breach detection
CN105213188A (zh) * 2011-07-28 2016-01-06 辽宁海思科制药有限公司 一种新的用于包装脂肪乳、氨基酸和葡萄糖注射液的三室输液袋
US9376655B2 (en) 2011-09-29 2016-06-28 Life Technologies Corporation Filter systems for separating microcarriers from cell culture solutions
WO2013049692A1 (en) 2011-09-30 2013-04-04 Hyclone Laboratories, Inc. Container with film sparger
US8820549B1 (en) 2011-11-17 2014-09-02 Christopher Estrada Multi-chamber nursing bottle having frangible portion for separately storing liquids and other substances
CN105267035A (zh) * 2012-07-27 2016-01-27 辽宁海思科制药有限公司 一种新的用于包装中长链脂肪乳、氨基酸和葡萄糖注射液的三室输液袋
US9266647B2 (en) * 2012-08-23 2016-02-23 Waterview Innovation, Llc Reusable shopping bag having multiple secondary uses
JP2015531725A (ja) 2012-08-23 2015-11-05 ウォータービュー・イノベーション・エルエルシーＷａｔｅｒｖｉｅｗ Ｉｎｎｏｖａｔｉｏｎ，Ｌｌｃ 不織繊維材料で形成された再利用可能な多目的袋
US20140373974A1 (en) * 2013-06-24 2014-12-25 Brandon Ragan Pouch-type Sealant Injector
DE102014202261A1 (de) * 2014-02-07 2015-08-27 Eurozyto Gmbh Behältnis und Set zur Bereitstellung parenteraler Nahrung
DE102014005569A1 (de) * 2014-04-16 2015-10-22 Fresenius Medical Care Deutschland Gmbh Mehrkammerbeutelöffnungshilfe
US9079690B1 (en) 2014-06-26 2015-07-14 Advanced Scientifics, Inc. Freezer bag, storage system, and method of freezing
ES2891785T3 (es) * 2015-04-23 2022-01-31 Hewlett Packard Development Co Contenedor de líquido
WO2017177058A1 (en) 2016-04-07 2017-10-12 Havi Global Solutions, Llc Fluid pouch with inner microstructure
JP7027350B2 (ja) * 2016-06-16 2022-03-01 デピュイ・シンセス・プロダクツ・インコーポレイテッド 滅菌マットを製造する方法及び手術用備品を滅菌する方法
US10589197B2 (en) 2016-12-01 2020-03-17 Life Technologies Corporation Microcarrier filter bag assemblies and methods of use
DE102017202510A1 (de) 2017-02-16 2018-08-16 Eurozyto Gmbh Behältnis zur Bereitstellung patientenspezifischer Arzneimittel
US10507165B2 (en) * 2017-05-31 2019-12-17 Adienne Pharma & Biotech Sa Multi chamber flexible bag and methods of using same
AU2018301395A1 (en) * 2017-07-11 2020-02-06 Universal Stabilization Technologies, Inc. Method for Preserving Biological Materials
KR102112136B1 (ko) * 2018-05-09 2020-05-18 고려대학교산학협력단 스마트 기능성 배액 시스템
USD900311S1 (en) 2018-05-18 2020-10-27 Baxter International Inc. Dual chamber flexible container
US20190350810A1 (en) 2018-05-18 2019-11-21 Baxter International Inc. Dual chamber flexible container and drug product using same
US20210212936A1 (en) * 2018-06-01 2021-07-15 Baxter International Inc. Parenteral nutrition formulation
US11419791B2 (en) 2018-07-05 2022-08-23 Fresenius Medical Care Holdings, Inc. Flexible container systems and nozzles, and related methods
US10888534B2 (en) 2019-04-26 2021-01-12 InfoRLife SA Storage stable ready-to-use norepinephrine aqueous solutions in flexible plastic bags
EP3838258A1 (en) 2019-12-17 2021-06-23 Baxter International Inc. Parenteral nutrition solution comprising a selenium source
EP3838278A1 (en) 2019-12-17 2021-06-23 Baxter International Inc Stabilization of selenite in a nutritional solution by dissolved oxygen
EP3878434A1 (en) 2020-03-12 2021-09-15 Lipoid GmbH Sunflower phospholipid composition containing phosphatidylcholine
US11666548B2 (en) 2020-06-05 2023-06-06 Baxter International Inc. Parenteral nutrition formulation
CN111728866A (zh) * 2020-07-27 2020-10-02 四川科伦药业股份有限公司 一种具有缓冲空腔的抗压型输液袋
EP3973950A1 (en) 2020-09-25 2022-03-30 Baxter International Inc Parenteral nutrition formulation comprising vitamin b12
EP3973949A1 (en) 2020-09-25 2022-03-30 Baxter International Inc Stabilization of vitamin a in a nutritional solution
US11389632B2 (en) * 2020-12-21 2022-07-19 Mediccene Inc. Intradermal drug delivery device
US11944586B2 (en) 2021-05-25 2024-04-02 Baxter International Inc. Containers with selective dissolved gas content
EP4140467A1 (en) * 2021-08-25 2023-03-01 B. Braun Melsungen AG Peel seam opening aid and method for opening peel seams of a multichamber bag
US20230172809A1 (en) 2021-12-07 2023-06-08 Baxter International Inc. Multi-chamber bag for parenteral nutrition solutions
US20230172806A1 (en) 2021-12-07 2023-06-08 Baxter International Inc. Multi-chamber bag for parenteral nutrition solutions
WO2023170680A1 (en) 2022-03-08 2023-09-14 Equashield Medical Ltd Fluid transfer station in a robotic pharmaceutical preparation system

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2502735B2 (de) 1975-01-23 1978-11-23 J. Pfrimmer & Co, 8520 Erlangen Verwendung von Glycerophosphaten
US4169811A (en) 1977-03-23 1979-10-02 Mitsubishi Gas Chemical Co., Inc. Oxygen indicator
DE2742875A1 (de) * 1977-09-23 1979-04-05 Merck Patent Gmbh Verfahren und mittel zur bestimmung von sauerstoff im blut
JPS568547A (en) * 1979-07-03 1981-01-28 Mitsubishi Gas Chem Co Inc Printable detecting agent
US4467588A (en) * 1982-04-06 1984-08-28 Baxter Travenol Laboratories, Inc. Separated packaging and sterile processing for liquid-powder mixing
US4491589A (en) * 1982-05-17 1985-01-01 The Trustees Of Columbia University In The City Of New York Amino acid solutions for parenteral nutrition and methods of formulation and use
JPS5916818A (ja) 1982-07-20 1984-01-28 Shimizu Seiyaku Kk 経静脈投与用輸液剤
US4526752A (en) * 1982-12-16 1985-07-02 Daniel Perlman Oxygen indicator for packaging
US4602910A (en) * 1984-02-28 1986-07-29 Larkin Mark E Compartmented flexible solution container
US4519499A (en) * 1984-06-15 1985-05-28 Baxter Travenol Laboratories, Inc. Container having a selectively openable seal line and peelable barrier means
US4608043A (en) * 1984-06-22 1986-08-26 Abbott Laboratories I.V. fluid storage and mixing system
JPH0813729B2 (ja) * 1987-03-06 1996-02-14 有恒薬品工業株式会社 害虫駆除用毒餌剤
US5096813A (en) 1988-07-18 1992-03-17 Massachusetts Institute Of Technology Visual indicator system
US4952068A (en) * 1989-03-21 1990-08-28 Flint Theodore R Static mixing device and container
DE4107223C1 (pt) * 1991-03-07 1992-09-10 Fresenius Ag, 6380 Bad Homburg, De
US5219524A (en) * 1991-05-07 1993-06-15 Everseal Preservation Labs., Inc. System and method for preserving acid-containing articles
TW205591B (pt) 1991-07-17 1993-05-11 Mitsubishi Gas Chemical Co
US5358876A (en) * 1991-07-17 1994-10-25 Mitsubishi Gas Chemical Company, Inc. Oxygen indicator
CN1046315C (zh) * 1991-10-11 1999-11-10 应浙鸿 一种多剂型厌氧指示剂
US5287961A (en) * 1992-10-23 1994-02-22 W.R. Grace & Co.-Conn. Multi-compartment package having improved partition strip
AU5637094A (en) * 1993-03-16 1994-09-22 Clintec Nutrition Company Peelable seal and container having same
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
JPH10504291A (ja) * 1994-07-22 1998-04-28 ジー．ディー．サール アンド カンパニー 自己乳化性ドラッグデリバリーシステム
US5549905A (en) * 1994-10-18 1996-08-27 Clintec Nutrition Co. Enternal composition for pediatric patients
US5756356A (en) 1995-03-31 1998-05-26 Toyo Ink Manufacturing Co., Ltd. Method of indicating time or temperature-time accumulated value as color change, and materials therefor
US5635199A (en) 1995-10-27 1997-06-03 Nestec Ltd. Support of pediatric patients
SE9601348D0 (sv) 1996-04-10 1996-04-10 Pharmacia Ab Improved containers for parenteral fluids
US5928213A (en) * 1996-05-13 1999-07-27 B. Braun Medical, Inc. Flexible multiple compartment medical container with preferentially rupturable seals
SE9602818D0 (sv) * 1996-07-19 1996-07-19 Pharmacia & Upjohn Ab Colored composition
SK6999A3 (en) * 1996-07-19 1999-08-06 Pharmacia & Upjohn Ab Color composition comprising an agent containing pyrogallol entities, a salt of iron (ii) and an organic acid
ZA978002B (en) * 1996-09-11 1998-03-02 Baxter Int Containers and methods for storing and admixing medical solutions.
DE19641909A1 (de) * 1996-10-11 1998-04-16 Braun Melsungen Ag Flexibler Kunststoffbehälter mit drei Kammern
CN1142757C (zh) * 1997-02-14 2004-03-24 布劳恩梅尔松根公开股份有限公司 软塑料容器
DE19718543A1 (de) * 1997-05-02 1998-11-05 Braun Melsungen Ag Flexibler, dichter Mehrkammerbeutel
US6676901B1 (en) * 1997-10-17 2004-01-13 Mitsubishi Gas Chemical Company, Inc. Oxygen indicator package equipped with oxygen indicator and method for manufacturing the same
US6074366A (en) * 1998-01-16 2000-06-13 Tandem Medical Inc. Medication delivery apparatus
CN2323794Y (zh) * 1998-04-01 1999-06-16 喻敏 分液式输液软袋
DE19820801A1 (de) * 1998-05-09 1999-11-25 Gruenenthal Gmbh Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten
US6561008B1 (en) * 1999-10-28 2003-05-13 Guelph Food Technology Centre Determination of oxygen permeation into containers
JP2002136570A (ja) * 2000-08-24 2002-05-14 Otsuka Pharmaceut Factory Inc 医療用複室容器
US20030099722A1 (en) * 2001-10-09 2003-05-29 Baxter Jeffrey H. Methods and compositions for providing glutamine
ATE423309T1 (de) * 2001-10-26 2009-03-15 Mitsubishi Gas Chemical Co Zusammensetzung zur bestimmung von sauerstoff
US7175614B2 (en) * 2002-10-17 2007-02-13 Baxter International Inc. Peelable seal
US7323206B1 (en) * 2003-03-04 2008-01-29 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
GB0305602D0 (en) * 2003-03-12 2003-04-16 Univ Strathclyde Indicator
US7651989B2 (en) * 2003-08-29 2010-01-26 Kimberly-Clark Worldwide, Inc. Single phase color change agents
US20050085577A1 (en) * 2003-09-11 2005-04-21 Ta Yen Ching Oxygen scavenging packaging having improved sensory properties
DE10345589A1 (de) * 2003-09-29 2005-05-04 Andre Schelbach Flakon
EP1621178A1 (en) * 2004-07-29 2006-02-01 Fresenius Kabi Deutschland GmbH Flexible multi-chamber container for the preparation of medical mixed solutions
EP1621177A1 (en) * 2004-07-29 2006-02-01 Fresenius Kabi Deutschland GmbH Medical container with improved peelable seal

Also Published As

Publication number Publication date
NZ565765A (en) 2010-01-29
IL189196A0 (en) 2008-06-05
ES2525930T3 (es) 2015-01-02
BRPI0614097B8 (pt) 2021-06-22
HK1121032A1 (en) 2009-04-17
US20070031976A1 (en) 2007-02-08
CN101287438A (zh) 2008-10-15
WO2007037793A1 (en) 2007-04-05
BRPI0614097A2 (pt) 2011-03-09
KR20080035667A (ko) 2008-04-23
AU2006275435B2 (en) 2011-10-06
JP2009502435A (ja) 2009-01-29
KR101333956B1 (ko) 2013-11-27
JP2009503549A (ja) 2009-01-29
WO2007016611A2 (en) 2007-02-08
CA2617230A1 (en) 2007-02-08
KR20080043804A (ko) 2008-05-19
CA2616928A1 (en) 2007-04-05
DK1909739T3 (da) 2011-03-21
AU2006295338B2 (en) 2011-11-17
RU2008107992A (ru) 2009-09-10
WO2007016615A1 (en) 2007-02-08
DE602006019259D1 (de) 2011-02-10
CN101287438B (zh) 2013-01-02
AU2006275439A1 (en) 2007-02-08
IL189197A (en) 2011-07-31
RU2008108005A (ru) 2009-09-10
BRPI0614606A2 (pt) 2011-04-05
RU2390324C2 (ru) 2010-05-27
AU2006295338A1 (en) 2007-04-05
IL189197A0 (en) 2008-06-05
IL189196A (en) 2011-09-27
MX2008001619A (es) 2008-04-07
EP1909739B1 (en) 2010-12-29
EP1909739A1 (en) 2008-04-16
IL189198A0 (en) 2008-06-05
US20070092579A1 (en) 2007-04-26
KR20080041229A (ko) 2008-05-09
CN101351179A (zh) 2009-01-21
NZ565764A (en) 2010-06-25
CA2616928C (en) 2014-10-07
HK1121031A1 (en) 2009-04-17
CA2617627C (en) 2015-02-24
US8485727B2 (en) 2013-07-16
US20070029001A1 (en) 2007-02-08
BRPI0614521A2 (pt) 2011-03-29
PT1909736E (pt) 2014-12-23
WO2007016611A3 (en) 2007-05-10
RU2405141C2 (ru) 2010-11-27
BRPI0614521B1 (pt) 2021-02-23
JP2009502436A (ja) 2009-01-29
MX2008001621A (es) 2008-11-10
EP1909737A1 (en) 2008-04-16
ES2358682T3 (es) 2011-05-12
CA2617627A1 (en) 2007-02-08
RU2008108007A (ru) 2009-09-10
KR101242905B1 (ko) 2013-03-12
BRPI0614097B1 (pt) 2017-12-05
CN101277670A (zh) 2008-10-01
EP1909736A2 (en) 2008-04-16
DK1909736T3 (en) 2014-12-01
ATE493105T1 (de) 2011-01-15
CN101277670B (zh) 2012-05-30
PT1909739E (pt) 2011-03-23
MX2008001620A (es) 2008-04-07
EP1909736B1 (en) 2014-11-12
AU2006275435A1 (en) 2007-02-08

Similar Documents

Publication Publication Date Title
BRPI0614521B8 (pt) indicador de oxigênio para uso em produtos médicos
CL2007003199A1 (es) Receptaculo con un ingrediente activo que comprende un cuerpo adaptado conteniendo un primer ingrediente activo y un par de filtros espaciados adaptados para retener el ingrediente activo dentro del receptaculo, permitiendo al mismo tiempo el paso de
IN2014MN00187A (pt)
WO2007120916A3 (en) Carrier packages and methods of erecting carrier packages
WO2008155059A3 (de) Kohlenwasserstoff gemische und ihre verwendung
EP2190401A4 (en) DEVICE, SEALING ELEMENT AND LIQUID CONTAINER
BR112014018608A8 (pt) Embalagem e método de embalar
EP1905584A3 (en) Packaging Inserts with Myoglobin Blooming Agents, Packages and Methods of Packaging
IL173807A0 (en) Amphiphilic antioxidant compounds, mitoquinone derivatives and pharmaceutical compositions containing the same
EP1724278A4 (en) NITROGEN-FILLED CORE DERIVATIVES, THERAPEUTIC COMPOSITIONS CONTAINING THESE DERIVATIVES AND THEIR USE AS MEDICAMENTS
BR112013009841A2 (pt) conector de bolsa e método relacionado
PL1712482T3 (pl) Torba foliowa
WO2008113483A3 (de) Stabilisierung von vitamin b12
BRPI0410701A (pt) produto farmacêutico estabilizado
EP2123249A4 (en) OIL SOLUTION AND AGENTS, MOISTURE BACKING AGENT AND PREPARATION THEREOF FOR TOPICAL APPLICATION
IL195935A0 (en) 18-methyl-19-nor-androst-4-en 17,17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-one) and pharmaceutical preparations containing the same
FR2919631B1 (fr) Bande de stabilisation renforcee destinee a etre utilisee dans des ouvrages en sol renforce
ES2195573T3 (es) Preparado farmaceutico solido con estructura multifase para administracion oral de gatifloxacina o sus sales o hidratos farmaceuticamente utilizables y procedimiento para su preparacion.
WO2004108540A3 (en) Carabiner device for containers
BR112014008939A2 (pt) artigo de embalagem termoencolhível de fácil abertura
RU2015131094A (ru) Закрывающее устройство для контейнера, их комбинация и способ их использования
BR112014009409A2 (pt) montagem de coleta de sangue
WO2008003025A8 (en) Packaging material for food items containing permeating oils
CL2011000741A1 (es) Unidad de envase con una plantilla plegable que comprende la unidad de envase con al menos una bolsa de alojamiento para al menos una tarjeta de burbujas y/o una seccion parcial de la tarjeta de burbujas o para otro producto de llenado.
EA200700689A1 (ru) Сохраняющая свежесть упаковка для удлиненных изделий

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: BAXTER INTERNATIONAL INC (US) , BAXTER HEALTHCARE

Free format text: ENDERECO DO 2O DEPOSITANTE ALTERADO CONFORME SOLICITADO NA PETICAO NO 020110115944/RJ DE 11/11/2011.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/02/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/08/2006, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO